Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE
2022-02-07 21:00
Samsung Biologics receives 2022 CMO Leadership Award in all six categories
2022-02-07 20:00
Ascletis Announces Positive Data of Oral Double Prodrug ASC10 and Its Antiviral Nucleoside Analog ASC10-A Against Omicron Variant
2022-02-07 19:00
The one-component Sputnik Light vaccine has been authorized in India; over 2.5 billion people live in countries that approved Sputnik Light as a standalone vaccine and a universal booster
2022-02-07 08:18
Everest Medicines Announces First Drug Approval of Trodelvy® in Singapore for Second-Line Metastatic Triple-Negative Breast Cancer
2022-02-07 08:00
Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors
2022-02-06 18:30
Vitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms
2022-02-04 17:23
Nanoform signs GMP manufacturing program with TargTex following formulation success
2022-02-04 15:54
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
2022-02-04 06:54
Mentice publishes the company's year-end report for the period January-December 2021
2022-02-03 15:37
CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma
2022-02-02 11:00
World's most trusted source for chemistry information, CAS, launches major biology expansion
2022-02-02 10:42
New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good
2022-02-01 21:00
Cytiva fuels biotech development in Australia and New Zealand
2022-02-01 07:00
DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA
2022-02-01 06:00
Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD)
2022-02-01 05:30
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
2022-02-01 04:06
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement
2022-01-31 19:00
HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital
2022-01-29 11:37
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China
2022-01-29 05:28
1
200
201
202
203
204
420